ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1737

RheumMadness 2024: The Practical Impact of the Practically Perfect Season

Eric Wilson1, Benjamin Lueck2, Sabahat Usmani3, Laura Arneson4, Meredith Balbach5, Lauren Phillips6, John Kellogg2, Courtney Bair7, Michael Macklin8, Iman Qaiser9, Amanda Rodriguez10, Akrithi Garren11, Nina Couette12, Melissa Briones13, Matthew Sparks7, Lisa Criscione-Schreiber2, Guy Katz14 and David Leverenz7, 1Duke University Hospital, Durham, NC, 2Duke University School of Medicine, Durham, NC, 3WEISS Memorial Hospital, Chicago, IL, 4Northwestern University, Chicago, IL, 5Vanderbilt University, Nashville, TN, 6University of Michigan, Ann Arbor, MI, 7Duke University, Durham, NC, 8University of Chicago, Chicago, IL, 9Choctaw Nation of Oklahoma Health Services Authority, McKinney, TX, 10Lankenau Medical Center, Philadelphia, PA, 11MedStar/Georgetown Washington Hospital Center, Silver Spring, MD, 12Genesis Healthcare System, Columbus, OH, 13Loyola University, Maywood, IL, 14Massachusetts General Hospital, Boston, MA

Meeting: ACR Convergence 2024

Keywords: education, medical, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Professional Education

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: RheumMadness is an online tournament of competing rheumatology concepts. The 2024 season focused on the practical impact of published manuscripts; to mirror this, we assessed the practical impact of the tournament on patient care and professional satisfaction among RheumMadness participants.

Methods: RheumMadness 2024 consisted of 16 teams of competing concepts presented as scouting reports. New this year, scouting report authors created visual aids to enhance the practical utility of their reports. Participants submitted brackets predicting matchup outcomes that were compared against the choices of a Blue Ribbon Panel (BRP). Following the tournament, participants completed a survey (excluding 4 leaders who created the survey: EW, BL, GK, DL). Respondents who agreed or strongly agreed that they could apply knowledge from RheumMadness 2024 were asked to describe at least one piece of knowledge they planned to apply. A narrative qualitative analysis was performed on the responses to uncover themes. To explore the impact of RheumMadness over time, surveys sent to participants who had engaged in a prior tournament included questions about the impact of RheumMadness on their professional activities. Prism v10.2.3 was used to graph and analyze data using Mann-Whitney U-tests to compare subgroups.

Results: There were 115 tournament participants (bracket submitters or BRP members) in 2024. We received 48 complete survey responses. Of those, 39 submitted a bracket or reported serving on the BRP (response rate 34% among 115 tournament participants). The remaining survey respondents did not submit a bracket or serve on the BRP but still engaged with RheumMadness content; therefore, all 48 responses were analyzed. Respondents included 22 (46%) attendings, 20 (42%) fellows, 5 (10%) residents/advanced practice providers in-training/medical students, and 1 (2%) “other”. 40 (83%) of these respondents reviewed half or more of the scouting reports. Among all respondents, 47 (96%) agreed/strongly agreed that RheumMadness 2024 helped them discover new concepts, and 40 (83%) agreed/strongly agreed that they could apply knowledge to their work, with no significant differences in agreement among attendings vs trainees, bracket submitters vs non-submitters, or scouting report authors vs non-authors (Figure 1). Most respondents agreed/strongly agreed that the visual aids helped them better understand (88%) and apply (78%) tournament concepts. Free-text responses described the application of knowledge in four areas: patient care, teaching, creation of a repository of useful references, and expansion of knowledge (Figure 2). Of the 26 respondents who had participated in a prior tournament, 22 (85%) indicated that RheumMadness made them happy, 19 (73%) reported applying knowledge to patient care, 12 (46%) reviewed content between tournaments, and 10 (38%) reported that participation strengthened their professional network (Figure 3).

Conclusion: RheumMadness has a practical impact by spreading knowledge that is applied to patient care, providing a useful repository of resources, strengthening professional networks, and increasing happiness.

Supporting image 1

Figure 1: RheumMadness 2024 impact on knowledge acquisition and application. Respondents were asked to rate their level of agreement (on a 1-5 Likert scale) with survey prompts about the tournament’s impact on their discovery of new concepts and their application of this newly acquired knowledge to their professional work. The proportion of total respondents (n=48) selecting a given level of agreement with survey prompts about knowledge acquisition (left, panel A) and knowledge application (right, panel B) are depicted in pie charts in the upper portion of the figure. Subgroup analyses comparing differing levels of agreement among attendings vs trainees (panels C & D, n=47 given 1 respondent self-identified as neither a trainee nor an attending), bracket submitters vs non-bracket submitters (panels E & F, n=48), and scouting report authors vs non-authors (panels G & H, n=48) were conducted using Mann-Whitney U-tests (knowledge acquisition, left – panels C, E, G; knowledge application, right – panels D, F, H). For panels C-H, the size of the colored bar corresponds to the proportion of respondents selecting a particular level of agreement. P-vales are displayed below the corresponding bar chart (p< 0.05 = statistically significant).

Supporting image 2

Figure 2: RheumMadness 2024 knowledge application – qualitative analysis. Outcomes of a narrative analysis of free text responses provided by participants who agreed or strongly agreed that they could effectively apply knowledge acquired from RheumMadness 2024 to their daily work (n=39) revealed that the tournament did so in four distinct, thematic categories (displayed in bold in the red, green, yellow, and blue colored boxes above; sample quotes corresponding to each of the four thematic categories are provided in italics).

Supporting image 3

Figure 3: RheumMadness impact on professional development. Survey respondents that had previously participated in a RheumMadness tournament (n=26) were asked to indicate the impact of participation on their professional activities over the preceding 1+ years. The proportion of respondents selecting each area of impact is depicted in the bar chart above (respondents could select multiple responses).


Disclosures: E. Wilson: None; B. Lueck: None; S. Usmani: None; L. Arneson: None; M. Balbach: None; L. Phillips: None; J. Kellogg: None; C. Bair: None; M. Macklin: None; I. Qaiser: None; A. Rodriguez: None; A. Garren: None; N. Couette: None; M. Briones: theMednet.org, 3, 11; M. Sparks: None; L. Criscione-Schreiber: UCB, 5; G. Katz: Amgen, 1, Evolve Medical Education, 6, Sana, 5, Sanofi, 5, Zenas, 5; D. Leverenz: Pfizer, 5, Rheumatology Research Foundation, 5, Sanofi, 2, UCB, 2.

To cite this abstract in AMA style:

Wilson E, Lueck B, Usmani S, Arneson L, Balbach M, Phillips L, Kellogg J, Bair C, Macklin M, Qaiser I, Rodriguez A, Garren A, Couette N, Briones M, Sparks M, Criscione-Schreiber L, Katz G, Leverenz D. RheumMadness 2024: The Practical Impact of the Practically Perfect Season [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/rheummadness-2024-the-practical-impact-of-the-practically-perfect-season/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheummadness-2024-the-practical-impact-of-the-practically-perfect-season/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology